NZ Lymphoma / Leukaemia Research Review Issue 28

In this issue:

Leukaemia selection

Chimeric antigen receptor T-cells in ALL
Bosutinib vs. imatinib safety in newly diagnosed chronic-phase CML
Obinutuzumab in relapsed/ refractory CLL
Long-term results of first salvage with RFC in CLL

Lymphoma selection

GDP vs. DHAP pre-SCT for relapsed/refractory aggressive lymphomas
Impact of induction and SCT on DHL outcomes
Relevance of bone-marrow biopsy in PET-CT-staged treatment-naive HL
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity in DLBCL
RCD in monoclonal Ig depositrelated glomerulopathy and indolent NHL
Routine post-therapy surveillance imaging in DLBCL

Please login below to download this issue (PDF)